PureTech Health and Royalty Pharma’s KarXT Royalty Agreement

Jones Day advised Royalty Pharma on the deal.Royalty Pharma have acquired a $500m interest in PureTech’s royalty in Karuna Therapeutics’ KarXT, with $100m cash up front…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now